Literature DB >> 17376781

Protein kinase C-mediated phosphorylation of the calcium-sensing receptor is stimulated by receptor activation and attenuated by calyculin-sensitive phosphatase activity.

Sarah L Davies1, Ai Ozawa, Wanda D McCormick, Melita M Dvorak, Donald T Ward.   

Abstract

The agonist sensitivity of the calcium-sensing receptor (CaR) can be altered by protein kinase C (PKC), with CaR residue Thr(888) contributing significantly to this effect. To determine whether CaR(T888) is a substrate for PKC and whether receptor activation modulates such phosphorylation, a phospho-specific antibody against this residue was raised (CaR(pT888)). In HEK-293 cells stably expressing CaR (CaR-HEK), but not in cells expressing the mutant receptor CaR(T888A), phorbol ester (PMA) treatment increased CaR(pT888) immunoreactivity as observed by immunoblotting and immunofluorescence. Raising extracellular Ca(2+) concentration from 0.5 to 2.5 mM increased CaR(T888) phosphorylation, an effect that was potentiated stereoselectively by the calcimimetic NPS R-467. These responses were mimicked by 5 mM extracellular Ca(2+) and abolished by the calcilytic NPS-89636 and also by PKC inhibition or chronic PMA pretreatment. Whereas CaR(T888A) did exhibit increased apparent agonist sensitivity, by converting intracellular Ca(2+) (Ca(2+)(i)) oscillations to sustained plateau responses in some cells, we still observed Ca(2+)(i) oscillations in a significant number of cells. This suggests that CaR(T888) contributes significantly to CaR regulation but is not the exclusive determinant of CaR-induced Ca(2+)(i) oscillations. Finally, dephosphorylation of CaR(T888) was blocked by the protein phosphatase 1/2A inhibitor calyculin, a treatment that also inhibited Ca(2+)(i) oscillations. In addition, calyculin/PMA cotreatment increased CaR(T888) phosphorylation in bovine parathyroid cells. Therefore, CaR(T888) is a substrate for receptor-induced, PKC-mediated feedback phosphorylation and can be dephosphorylated by a calyculin-sensitive phosphatase.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376781     DOI: 10.1074/jbc.M607469200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Engendering biased signalling from the calcium-sensing receptor for the pharmacotherapy of diverse disorders.

Authors:  K Leach; P M Sexton; A Christopoulos; A D Conigrave
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

2.  Defining protein kinase/phosphatase isoenzymic regulation of mGlu₅ receptor-stimulated phospholipase C and Ca²⁺ responses in astrocytes.

Authors:  S J Bradley; R A J Challiss
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 3.  Mechanisms of multimodal sensing by extracellular Ca(2+)-sensing receptors: a domain-based survey of requirements for binding and signalling.

Authors:  Mahvash A Khan; Arthur D Conigrave
Journal:  Br J Pharmacol       Date:  2010-02-05       Impact factor: 8.739

4.  Intracellular Ca2+ oscillations generated via the Ca2+-sensing receptor are mediated by negative feedback by PKCα at Thr888.

Authors:  Steven H Young; Osvaldo Rey; James Sinnett-Smith; Enrique Rozengurt
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

5.  Intracellular Ca(2+) oscillations generated via the extracellular Ca(2+)-sensing receptor (CaSR) in response to extracellular Ca(2+) or L-phenylalanine: Impact of the highly conservative mutation Ser170Thr.

Authors:  Steven H Young; Osvaldo Rey; Enrique Rozengurt
Journal:  Biochem Biophys Res Commun       Date:  2015-09-30       Impact factor: 3.575

Review 6.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

7.  The calcium-sensing receptor is necessary for the rapid development of hypercalcemia in human lung squamous cell carcinoma.

Authors:  Gwendolen Lorch; Serge Viatchenko-Karpinski; Hsiang-Ting Ho; Wessel P Dirksen; Ramiro E Toribio; John Foley; Sandor Györke; Thomas J Rosol
Journal:  Neoplasia       Date:  2011-05       Impact factor: 5.715

8.  Calmodulin regulates Ca2+-sensing receptor-mediated Ca2+ signaling and its cell surface expression.

Authors:  Yun Huang; Yubin Zhou; Hing-Cheung Wong; Adriana Castiblanco; Yanyi Chen; Edward M Brown; Jenny J Yang
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

9.  Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells.

Authors:  Ramanaiah Mamillapalli; Joshua VanHouten; Walter Zawalich; John Wysolmerski
Journal:  J Biol Chem       Date:  2008-07-11       Impact factor: 5.157

10.  Hypothermia and pharmacological regimens that prevent overexpression and overactivity of the extracellular calcium-sensing receptor protect neurons against traumatic brain injury.

Authors:  Jong Youl Kim; Nuri Kim; Midori A Yenari; Wenhan Chang
Journal:  J Neurotrauma       Date:  2013-07-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.